"Evaluation Of ALBA® Device for Upper Extremity Motor Function In Adults With Subacute And Chronic Acquired Brain Injury"

Launched by UMOV · Apr 19, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the ALBA® device, a robotic tool designed to help improve the use of the arm and hand in adults who have had a stroke or other brain injuries. The goal is to see if using this device alongside traditional therapy can help patients regain better control and movement in their arms compared to just receiving standard treatment. Participants will be split into two groups: one will receive only usual therapy, while the other will use the ALBA® device along with some standard therapy. Each participant will train for 45 minutes, five days a week, for four weeks.

To be eligible for this study, participants must be patients at the Los Coihues clinic and have a brain injury that affects their arm movements but still allows them to follow instructions. They should also have some level of control over their trunk and must be in the subacute or chronic stage of recovery (up to two years after their injury). It's important to note that individuals with certain severe conditions, such as significant heart issues or serious cognitive impairments, will not be included in the trial. Participants can expect to be assessed before starting the training, after four weeks, and again three months later to see how their arm function improves.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of Los Coihues clinic Diagnosis of acquired brain injury. Cognitive capacity and language that allows understanding and following the therapist's instructions.
• • Trunk control. Subacute and chronic stage (up to 2 years post injury). Upper extremity paresis able to perform movements with eliminated gravity (modified MRC 2).
• Exclusion Criteria:
• • Cardiovascular instability Visual or acoustic limitations. Severe hypertonia (≥3 Ashworth Scale). Upper extremity with passive joint limitation and/or traumatic injury. Neuropsychological alteration (global aphasia, severe attentional deficit, spatial perception alteration).
• • Moderate to severe cognitive-behavioral alterations that do not allow the understanding of instructions.
• • Severe alterations of consciousness. Deficit in cephalic control. Severe deficit in sedentary balance.